FH and hereditary leiomyomatosis and renal cell cancer: In order to test whether this could be extended to HLRCC, the metabolic profile of spent media of the patient-derived FH-deficient renal cancer cell line UOK262 [22], indicated hereafter as UOK, was compared to FH-reconstituted UOK cells (UOKpFH) [10].